Testing effectiveness (Phase 2)Not Yet RecruitingNCT07020260
What this trial is testing
The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
Who this might be right for
LeukemiaLymphoma
Princess Maxima Center for Pediatric Oncology 18